Top in rheumatology: FDA action on tanezumab, unapproved CBD products

Retrieved on: 2021-04-02 10:07:30

Tags for this article:

Click the tags to see associated articles and topics

Top in rheumatology: FDA action on tanezumab, unapproved CBD products. View article details on hiswai:

Excerpt

FDA warns against 'unapproved CBD products' touting arthritis pain relief. The FDA has issued warning letters to Honest Globe Inc. and Biolyte ...

Article found on: www.healio.com